We believe investors with a long-term horizon should stay invested in MRK stock, while short-term investors should consider selling the same.
Two men were arraigned in federal court Friday after they were extradited from Singapore in February to face nearly 30 felony charges for allegedly selling counterfeit medication in King County.
16h
Hosted on MSNPharma Stock Roundup: LLY Ups U.S. Manufacturing Investments & MoreEli Lilly LLY announced that it is increasing its manufacturing capacity in the United States by building four new plants.
We recently published a list of 10 Best Magic Formula Stocks for 2025. In this article, we are going to take a look at where ...
Rare Disease Day, an annual gathering hosted by the FDA and National Institutes of Health, was postponed. Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a ...
Berenberg analyst Luisa Hector lowered the firm’s price target on Merck (MRK) to $115 from $125 and keeps a Buy rating on the shares. Merck ...
FDA recently announced new safety requirements for DPD screening in cancer patients. Kristine Ashcraft, founder and CEO of ...
LLY is increasing its manufacturing capacity in the United States by building four new plants. AZN's phase III study on camizestrant meets primary endpoint.
Q4 and full-year 2024 revenues surged to $1.1B and $3.8B respectively. Check out why I rate ONC stock as a Buy.
AbbVie (ABBV) announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use adopted an opinion recommending the ...
The life sciences industry experienced a dynamic year in 2024. As the public markets gained traction, IPO activity and venture investment saw ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results